Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence

Cancer Immunology, Immunotherapy

Volumn 56, Issue 12, 2007, Pages 1993-2001

  Cui, Guanglin ^a,b   Yuan, Aping ^a,b   Goll, Rasmus ^a,b   Olsen, Trine ^a,b   Husebekk, Anne ^a   Vonen, Barthold ^b   Florholmen, Jon ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Anti tumor immunity; Colorectal adenoma carcinoma sequence; Cytokine; Dendritic cell; Premalignant lesions

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; MESSENGER RNA;

ADULT; AGED; ARTICLE; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL; TUMOR IMMUNITY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA; COLORECTAL NEOPLASMS; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-12; MALE; MIDDLE AGED; MUCOUS MEMBRANE; RNA, MESSENGER;

EID: 34848835778     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0345-9     Document Type: Article

References (39)

1. Fearon ER (1994) Molecular genetic studies of the adenoma-carcinoma sequence. Adv Intern Med 39:123-147
2. Fodde R (2002) The APC gene in colorectal cancer. Eur J Cancer 38(7):867-871
3. Muto T, Nagawa H, Watanabe T, Masaki T, Sawada T (1997) Colorectal carcinogenesis: historical review. Dis Colon Rectum 40(10 Suppl):S80-85
4. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21(2):137-148
5. Contasta I, Berghella AM, Pellegrini P, Adorno D (2003) Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions. Cancer Biother Radiopharm 18(4):549-557
6. Contasta I, Pellegrini P, Berghella AM, Beato TD, Adorno D (2006) Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy. Cancer Biother Radiopharm 21(5):488-505
7. Cui G, Goll G, Olsen T, Steigen S, Husebekk A, Vonen B, Florholmen J (2006) Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum. Cancer Immunol Immunother Dec 8; (Epub ahead of print)
8. Filipe MI, Mughal S, Bussey HJ (1980) Patterns of mucus secretion in the colonic epithelium in familial polyposis. Invest Cell Pathol 3(4):329-343
9. Filipe MI, Cooke KB (1974) Changes in composition of mucin in the mucosa adjacent to carcinoma of the colon as compared with the normal: a biochemical investigation. J Clin Pathol 27(4):315-318
10. Dawson PA, Filipe MI (1976) An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon. Cancer 37(5):2388-2398
11. Filipe MI, Branfoot AC (1974) Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer 34(2):282-290
12. Shamsuddin AK, Weiss L, Phelps PC, Trump BF (1981) Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon. J Natl Cancer Inst 66(2):413-419
13. Hao CY, Moore DH, Wong P, Bennington JL, Lee NM, Chen LC (2005) Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer. Clin Cancer Res 11(4):1400-1407
14. Hao CY, Moore DH, Chiu YS, Wong P, Bennington JL, Smith AP, Chen LC, Lee NM (2005) Altered gene expression in normal colonic mucosa of individuals with polyps of the colon. Dis Colon Rectum 48(12):2329-2335
15. Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, Brotman M, Moretto J, Mendes F, Smith AP, Bennington JL, et al (2004) Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res 64(10):3694-3700
16. Kuniyasu H, Yasui W, Shinohara H, Yano S, Ellis LM, Wilson MR, Bucana CD, Rikita T, Tahara E, Fidler IJ (2000) Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 157(5):1523-1535
17. Kuniyasu H, Ohmori H, Sasaki T, Sasahira T, Yoshida K, Kitadai Y, Fidler IJ (2003) Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Clin Cancer Res 9(13):4802-4810
18. Fox SH, Whalen GF, Sanders MM, Burleson JA, Jennings K, Kurtzman S, Kreutzer D (1998) Angiogenesis in normal tissue adjacent to colon cancer. J Surg Oncol 69(4):230-234
19. Cui G, Olsen T, Christiansen I, Vonen B, Florholmen J, Rasmus G (2006) Improvement of real-time PCR for quantifying TNF-a mRNA expression in inflamed colorectal mucosa-An approach to optimize procedures for clinical use. Scand J Clin Lab Invest 66(3):249-259
20. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI (2000) Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6(5):1755-1766
21. Ratta M, Fagnoni F, Curti A, Vescovini R, Sansoni P, Oliviero B, Fogli M, Ferri E, Della Cuna GR, Tura S, et al (2002) Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood 100(1):230-237
22. Sombroek CC, Stam AG, Masterson AJ, Lougheed SM, Schakel MJ, Meijer CJ, Pinedo HM, van den Eertwegh AJ, Scheper RJ, de Gruijl TD (2002) Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 168(9):4333-4343
23. Sharma S, Stolina M, Yang SC, Baratelli F, Lin JF, Atianzar K, Luo J, Zhu L, Lin Y, Huang M, et al (2003) Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin Cancer Res 9(3):961-968
24. Suzuki N, Yoshida A, Nakano Y (2005) Quantitative analysis of multi-species oral biofilms by TaqMan Real-Time PCR. Clin Med Res 3(3):176-185
25. Cui G, Koh TJ, Chen D, Zhao CM, Takaishi S, Dockray GJ, Varro A, Rogers AB, Fox JG, Wang TC (2004) Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res 64(22):8160-8166
26. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58(16):3491-3494
27. Schwaab T, Weiss JE, Schned AR, Barth RJ Jr (2001) Dendritic cell infiltration in colon cancer. J Immunother 24(2):130-137
28. Dalerba P, Maccalli C, Casati C, Castelli C, Parmiani G (2003) Immunology and immunotherapy of colorectal cancer. Crit Rev Oncol Hematol 46(1):33-57
29. Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN (1998) Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 4(3):585-593
30. Botella-Estrada R, Dasi F, Ramos D, Nagore E, Herrero MJ, Gimenez J, Fuster C, Sanmartin O, Guillen C, Alino S (2005) Cytokine expression and dendritic cell density in melanoma sentinel nodes. Melanoma Res 15(2):99-106
31. Lee JH, Torisu-Itakara H, Cochran AJ, Kadison A, Huynh Y, Morton DL, Essner R (2005) Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res 11(1):107-112
32. Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M, Ohta A, Koda T, Nishimura S (2000) The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol 46(Suppl):S52-S61
33. Yu P, Fu YX (2006) Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 86(3):231-245
34. Brigati C, Noonan DM, Albini A, Benelli R (2002) Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 19(3):247-258
35. O'Sullivan C, Lewis CE (1994) Tumour-associated leucocytes: friends or foes in breast carcinoma. J Pathol 172(3):229-235
36. Lenahan C, Avigan D (2006) Dendritic cell defects in patients with cancer: mechanisms and significance. Breast Cancer Res 8(1):101
37. Underwood JC (1974) Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer 30(6):538-548
38. Dave BJ, Hopwood VL, Hughes JI, Jackson GL, Melillo D, Pathak S (1993) Cytogenetic abnormalities in colon cancer patients: a comparison of T- and B-lymphocytes. Anticancer Res 13(2):433-438
39. Chaux P, Moutet M, Faivre J, Martin F, Martin M (1996) Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab Invest 74(5):975-983